Text Size

Remote Ischemic Postconditioning During Percutaneous Coronary Interventions (RIP-PCI)

This study is currently recruiting participants.
Verified May 2013 by Lawson Health Research Institute
Sponsor:
Information provided by (Responsible Party):
Shahar Lavi, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT00970827
First received: July 9, 2009
Last updated: May 10, 2013
Last verified: May 2013
History of Changes
  Purpose

Angioplasty is a commonly performed procedure for treating blockage of the blood vessels in the heart. Although this procedure is usually successful, it is often accompanied by a small degree of damage to the heart (i.e., small heart attack).

The purpose of this study is to find out if inflating a blood pressure cuff on the arm or the leg at the time of angioplasty for several minutes has a beneficial effect.

Patients will be assigned to one of three treatment groups: inflating blood pressure cuff on the arm, inflating blood pressure cuff on the leg and a control group.


Condition Intervention Phase
Coronary Artery Disease
 Procedure: remote ischemic postconditioning
 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Caregiver, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Remote Ischemic Postconditioning During Percutaneous Coronary Interventions.

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Lawson Health Research Institute:

Primary Outcome Measures:
  • Myocardial injury after PCI. [ Time Frame: 24 hours ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • To study the effects of different degrees of remote ischemic postconditioning on myocardial necrosis and inflammation following PCI. [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Platelet function [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  • Endothelial function [ Time Frame: 24 hours ] [ Designated as safety issue: No ]

Estimated Enrollment: 360
Study Start Date: May 2009
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 1
Leg postconditioning
 Procedure: remote ischemic postconditioning
Three 5- minute cycles of blood pressure cuff inflation according to the assigned group. The cuff is inflated to 200 mm Hg (and at least 20 mmHg above the systolic blood pressure) for 5 minutes followed by a 5-minute deflation (reperfusion).
Active Comparator: 2
Arm postconditioning
 Procedure: remote ischemic postconditioning
Three 5- minute cycles of blood pressure cuff inflation according to the assigned group. The cuff is inflated to 200 mm Hg (and at least 20 mmHg above the systolic blood pressure) for 5 minutes followed by a 5-minute deflation (reperfusion).
Placebo Comparator: 3
Control group
 Procedure: remote ischemic postconditioning
Three 5- minute cycles of blood pressure cuff inflation according to the assigned group. The cuff is inflated to 200 mm Hg (and at least 20 mmHg above the systolic blood pressure) for 5 minutes followed by a 5-minute deflation (reperfusion).

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients scheduled for PCI

Exclusion Criteria:

  • Acute myocardial infarction
  • Myocardial infarction or coronary bypass surgery during the last 4 weeks before PCI
  • Use of Glyburide
  • Heart failure (NYHA III/IV)
  • Chronic inflammatory disease
  • Severe renal impairment
  • Significant peripheral vascular disease
  • Unsuitable for use of an embolic protection device for PCI to SVG
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00970827

Contacts
Contact: Shahar Lavi, MD 519-6633611 shahar.lavi@lhsc.on.ca

Locations
Canada, Ontario
London Health Sceinces Centre Recruiting
London, Ontario, Canada, N6A5A5
Principal Investigator: Shahar Lavi, MD            
Sponsors and Collaborators
Lawson Health Research Institute
Investigators
Principal Investigator: Shahar Lavi, MD Lawson Health Research Institute
  More Information

No publications provided

Responsible Party: Shahar Lavi, Principal Investigator, Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT00970827     History of Changes
Other Study ID Numbers: R-09-015, 15664
Study First Received: July 9, 2009
Last Updated: May 10, 2013
Health Authority: Canada: Ethics Review Committee

Keywords provided by Lawson Health Research Institute:
Coronary artery disease
PCI
Postconditioning
Elective or urgent PCI

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
 Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on May 22, 2013